Similarly, miR-448 expression was downregulated in NSCLC and lower level was linked to a worse patient prognosis; however, miR-448 upregulation slowed the progression of NSCLC due to inhibiting EPHA7 and blocking the PI3K/AKT signaling pathway (58). This evidence concerns the gene AKT1 and non-small cell lung carcinoma.